Nano-X Imaging Ltd. (NNOX) stock soared 16% intraday on Monday, following a bullish analyst report that initiated coverage on the medical imaging technology company with a Buy rating.
D. Boral Capital analyst Jason Kolbert initiated coverage on Nano-X Imaging with a Buy rating and a $23 price target. Kolbert cited the company's innovative Nanox.ARC digital X-ray technology as a disruptive force in the medical imaging market, positioning Nano-X at the forefront of making early cancer detection more accessible and affordable.
The analyst's optimism about Nano-X Imaging's prospects and potential for growth in the rapidly evolving medical imaging space fueled investor enthusiasm, driving the stock's significant intraday surge.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.